Activating a person’s immune response against cancer is one of the most exciting advances in cancer therapy   Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Normally our immune system fails to recognise cancer cells, as they can look like normal cells in our body and are

    Project: Resistance to treatments for Multiple Myeloma  Institution: Institute of Cancer Research, London (UK)  Researcher: Dr. Charlotte Pawlyn  What is this project about?   This research project aims to define a profile of multiple myeloma patients likely to develop resistance to myeloma treatments, study reasons why such resistance occurs and develop useful therapeutic strategies to overcome this.    What is multiple myeloma?    Multiple myeloma is a cancer that begins in

Principal Investigators: Dr Alberto Ocaña, Dr Atanasio Pandiella Centres:  CHUA (University Hospital Complex of Albacete) – Albacete and CIC (Cancer Research Centre) – Salamanca Current situation   Breast cancer is the most common type of cancer in women. It is estimated that one in ten women may suffer from it at some point in their lives. Although

CRIS is strongly committed to training medical and research personnel, with the goal of positioning itself as the global vanguard in cancer research and treatment.   In 2017, the CRIS Foundation financed 10 research fellowships, lasting between six months and one year, to allow Spanish researchers travel to centres of reference abroad and acquire expertise

El cáncer de ovario representa el sexto tumor más frecuente dentro de la población femenina en España. Tiene una mortalidad elevada, ya que no hay métodos de detección precoz y se suele diagnosticar cuando ya se encuentra diseminado.

Principal Researcher: Dr David Olmos and Dr Elena Castro. Centres: Spanish National Cancer Research Centre (CNIO), IBIMA (Biomedical Research Institute of Malaga). Background: Prostate cancer is the most common cancer in men in the western world and its incidence increases year on year. It already ranks third as a cause of male cancer death, after

Researcher leading the project: Dr. Joaquín Martínez Centres developing the research: 12 de Octubre University Hospital, Madrid, Spanish National Cancer Research Centre (CNIO). Context Haematological or blood cancer is a type of cancer that affects your blood cells. Over 40,000 people are diagnosed with a blood cancer each year in the UK, and over 250,000 people are currently

Principal Researcher: Professor Chris Jones Centres: The Institute of Cancer Research (ICR) – London. UK Background: The appearance of brain tumours in children is a devastating event. There are hardly any effective treatments currently and average survival time for children after diagnosis is no longer than a year. This makes it imperative to improve diagnoses